[COMORBIDITIES IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA]

S A Fetesku, С. А. Фетеску
Likars'ka sprava · 2015 · pp. 157–9 · PMID:26118061 · W2419156870
Observational OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-13 ⓘ

This study evaluated comorbidities in patients with endometrial hyperplasia, finding that 50% had concomitant somatic pathology, primarily obesity, metabolic syndrome, and gastrointestinal or cardiovascular disorders.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The aim was to evaluate the prevalence of concomitant somatic pathology in patients with endometrial hyperplasia. It is shown that the incidence of endometrial hyperplastic processes of combination and somatic pathology is 50%. The main types of comorbid diseases are obesity, metabolic syndrome, gastrointestinal and cardiovascular disorders.

My notes (saved in your browser only)

MeSH descriptors

Cardiovascular Diseases Endometrial Hyperplasia Gastrointestinal Diseases Metabolic Syndrome Obesity Cardiovascular Diseases Cardiovascular Diseases Cardiovascular Diseases Comorbidity Endometrial Hyperplasia Endometrial Hyperplasia Endometrial Hyperplasia Female Gastrointestinal Diseases Gastrointestinal Diseases Gastrointestinal Diseases Humans Metabolic Syndrome Metabolic Syndrome Metabolic Syndrome

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:15:47.164179+00:00
License: CC0 · commercial use OK